S.A. Vartanian
Papers
1
Total Citations
30
H-Index
1
About
Dr. S.A. Vartanian is a leading researcher in urologic oncology, with a focused expertise in the comparative effectiveness and cost-efficiency of minimally invasive treatments for renal tumors. Her major contributions center on evaluating percutaneous cryoablation against established surgical standards, particularly for T1a renal masses. In her seminal 2015 study, "Percutaneous Cryoablation vs Partial Nephrectomy: Cost Comparison of T1a Tumors," cited over 30 times, Dr. Vartanian provided critical hospital-perspective cost analyses, retrospectively comparing 37 cryoablations to 26 open and 102 robot-assisted partial nephrectomies. This work has been instrumental in guiding clinical decision-making by demonstrating the economic and procedural advantages of cryoablation, helping to shape modern treatment paradigms for small renal masses. Her research is widely recognized for bridging the gap between clinical outcomes and healthcare economics, offering actionable insights for surgeons and hospital administrators alike. Dr. Vartanian’s work continues to influence the adoption of cost-conscious, patient-centered approaches in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1